New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Dry Powder Inhalers: A Double Win for COPD and Environment By Dennis Thompson HealthDay ReporterTUESDAY, Feb. 24, 2026 (HealthDay News) — Dry powder inhalers might provide a double benefit for people ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global dry powder inhaler market is set to witness sustained growth over the forecast period, driven by the increasing prevalence of respiratory disorders, ...

She says the new medication is harder to use ...

Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a technical collaboration with COVIRIX Medical Pty Ltd ("COVIRIX Medical"), an Australian ...

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five ...

Move comes 2 years after controversial exit of brand-name product ...

Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable and connected solutions, addressing chronic conditions like asthma and ...

With many diabetes mellitus (DM) patients struggling with the challenges of multiple daily insulin injections, there is a growing need for convenient and needle-free insulin delivery ...